[cat] El carcinoma ductal invasiu en fase inicial mostra altes taxes de supervivència a causa de la detecció precoç i els tractaments. No obstant això, encara hi ha possibilitats de recaiguda del 3% al 15% després del tractament.
Vidal Puigserver, Maria Francisca
core
Associations of the HER2DX Genomic Test with Biological and Pathologic Features in HER2-Positive Breast Cancer. [PDF]
Sanfeliu E +28 more
europepmc +1 more source
Immune-related adverse events among patients with early-stage triple-negative breast cancer treated with pembrolizumab plus chemotherapy: real-world data from the Neo-Real/GBECAM 0123 study. [PDF]
Andrade MO +26 more
europepmc +1 more source
Mitogenomic Alterations in Breast Cancer: Identification of Potential Biomarkers of Risk and Prognosis. [PDF]
Pérez-Amado CJ +10 more
europepmc +1 more source
La cirugía del cáncer de mama ha ido evolucionando desde un tratamiento localmente muy agresivo a tratamientos locales muy conservadores, con los mismos resultados oncológicos y con menor morbilidad y afectación estética, lo que favorece la recuperación psicológica de la paciente.
openaire +1 more source
Identification and Computational Analysis of <i>BRCA2</i> Variants in Mexican Women from Jalisco, Mexico, with Breast and Ovarian Cancer. [PDF]
García-Verdín PM +16 more
europepmc +1 more source
Futility in healthcare among Mexican female patients with breast cancer in advanced stage: The patient perspective. [PDF]
Namba-Bando MDMY +3 more
europepmc +1 more source
Difficult removal of a totally implantable venous access device 12 years after implantation: a case report and literature review. [PDF]
Boukat AK +3 more
europepmc +1 more source
Hormone therapy and cancer risks in transgender people: a systematic review. [PDF]
Uchimura LYT +5 more
europepmc +1 more source

